4534.T
Mochida Pharmaceutical Co Ltd
Price:  
2,993 
JPY
Volume:  
27,900
Japan | Pharmaceuticals

4534.T WACC - Weighted Average Cost of Capital

The WACC of Mochida Pharmaceutical Co Ltd (4534.T) is 6.0%.

The Cost of Equity of Mochida Pharmaceutical Co Ltd (4534.T) is 6%.
The Cost of Debt of Mochida Pharmaceutical Co Ltd (4534.T) is 4.25%.

RangeSelected
Cost of equity5.2% - 6.8%6%
Tax rate27.1% - 27.7%27.4%
Cost of debt4.0% - 4.5%4.25%
WACC5.1% - 6.8%6.0%
WACC

4534.T WACC calculation

CategoryLowHigh
Long-term bond rate1.4%1.9%
Equity market risk premium6.1%7.1%
Adjusted beta0.610.63
Additional risk adjustments0.0%0.5%
Cost of equity5.2%6.8%
Tax rate27.1%27.7%
Debt/Equity ratio
00
Cost of debt4.0%4.5%
After-tax WACC5.1%6.8%
Selected WACC6.0%

4534.T's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 4534.T:

cost_of_equity (6.00%) = risk_free_rate (1.65%) + equity_risk_premium (6.60%) * adjusted_beta (0.61) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.